Brenig
formerly Brenig TherapeuticsBrenig is an artificial intelligence company in Dover, United States, founded in 2021. It has 1 recorded funding round, most recently a Series A in July 2024.
Developing innovative small-molecule therapies to address fundamental disease mechanisms.
- Headquarters
- Dover, Delaware
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- brenigther.com
- Last Round
- Series AJul 2024
- Rounds
- 1
Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.
About
Brenig Therapeutics is a neurology-focused small molecule drug development company that applies an AI/ML-based discovery platform — developed in partnership with Expert Systems Inc. — to identify and advance best-in-class therapies for neurodegenerative diseases. Its lead program, BT-267, is a brain-selective LRRK2 inhibitor designed for the treatment of idiopathic and LRRK2-mutated Parkinson's disease, with a pharmacokinetic profile optimized for high sustained brain exposure and minimal peripheral toxicity. A second asset, BT-409, is a brain-selective NLRP3 inhibitor that entered its first-in-human Phase 1 clinical trial in January 2026, initially in healthy volunteers. Brenig closed a $65 million Series A in July 2024 led by NEA, with participation from OrbiMed, Torrey Pines Investments, and BioGeneration Ventures. The company appointed David L. Lucchino as CEO and Tien Dam as Chief Medical Officer in 2025.
Summary
It lists 11–50 employees. Its most recent funding was a Series A round in Jul 2024. Investors include OrbiMed, Torrey Pines Investment and BioGeneration Ventures.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jul 2024
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/brenig"><img src="https://indexed.vc/api/badge/company/brenig" alt="Brenig on Indexed.vc" width="260" height="76" /></a>